Down-regulation of mast cell responses through ITIM containing inhibitory receptors

Advances in Experimental Medicine and Biology

Volumn 716, Issue , 2011, Pages 143-159

  Karra, Laila ^a   Levi Schaffer, Francesca ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD200 RECEPTOR; CD300A PROTEIN; CD31 ANTIGEN; CD72 ANTIGEN; FC EPSILON RECEPTOR I; FC RECEPTOR; FC RECEPTOR IIA; FC RECEPTOR IIB; GLYCOPROTEIN; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN RECEPTOR; MAST CELL FUNCTION ASSOCIATED ANTIGEN; PAIRED IMMUNOGLOBULIN LIKE RECEPTOR B; PROTEIN LAIR 1; PROTEIN LILR; PROTEIN SIRP ALPHA; SIGLEC PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR;

ARTICLE; CELL ACTIVATION; CELLULAR IMMUNITY; HUMAN; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; IMMUNORECEPTOR TYROSINE BASED INHIBITION MOTIF; IMMUNORECEPTOR TYROSINE BASED SWITCH MOTIF; IMMUNOREGULATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; AGED; CYTOLOGY; DOWN REGULATION; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

AGED; DOWN-REGULATION; HUMANS; MAST CELLS; RECEPTORS, CELL SURFACE;

EID: 79960915632     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-9533-9_9     Document Type: Article

References (92)

1. Isakov N, ITIMs and ITAMs. The Yin and Yang of antigen and Fc receptor-linked signaling machinery. Immunol Res 1997; 16(1):85-100. (Pubitemid 27129631)
2. Barrow AD, Trowsdale J. You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling. Eur J Immunol 2006; 36(7):1646-53. (Pubitemid 44089030)
3. Koj A. Termination of acute-phase response: role of some cytokines and anti-inflammatory drugs. Gen Pharmacol 1998; 31(1):9-18. (Pubitemid 28239747)
4. Nicholson DW. Caspase structure, proteolytic substrates and function during apoptotic cell death. Cell Death Differ 1999; 6(11):1028-42.
5. Vaux DL, Korsmeyer SJ. Cell death in development. Cell 1999; 96(2):245-54. (Pubitemid 29059354)
6. Guicciardi ME, Gores GJ. Life and death by death receptors. FASEB J 2009; 23(6):1625-37.
7. Karra L et al. Are we ready to downregulate mast cells? Curr Opin Immunol 2009; 21(6):708-14.
8. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008; 8(5):349-61. (Pubitemid 351595216)
9. Bachelet I, Levi-Schaffer F, Mekori YA. Mast cells: not only in allergy. Immunol Allergy Clin North Am 2006; 26(3):407-25. (Pubitemid 44247537)
10. Piliponsky AM et al. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 2003; 101(5):1898-904. (Pubitemid 36237591)
11. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nature Reviews in Immunology 2007; 7(2):93-104. (Pubitemid 46174857)
12. Rocha-de-Souza CM et al. Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 molecules. Infect Immun 2008; 76(10):4489-97.
13. Lebbink RJ, Meyaard L. Non-MHC ligands for inhibitory immune receptors: novel insights and implications for immune regulation. Mol Immunol 2007; 44(9):2153-64. (Pubitemid 46097121)
14. Daeron M, Jaeger S, Du Pasquier L et al. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol Rev 2008; 224:11-43.
15. Cantoni C, Bottino C, Augugliaro R et al. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol 1999; 29(10):3148-59. (Pubitemid 29484205)
16. Abramson J, Rozenblum G, Pecht I. Stable knockdown of MAFA expression in RBL-2H3 cells by siRNA retrovirus-delivery system. Immunol Lett 2004; 92(1-2):179-84. (Pubitemid 38470066)
17. Drickamer K, Taylor ME. Biology of animal lectins. Annu Rev Cell Biol 1993; 9:237-64.
18. Izawa K, Kitaura J, Yamanishi Y et al. An activating and inhibitory signal from an inhibitory receptor LMIR3/CLM-1: LMIR3 augments lipopolysaccharide response through association with FcRgamma in mast cells. J Immunol 2009; 183(2):925-36.
19. Eissmann P, Beauchamp L, Wooters J et al. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 2005; 105(12):4722-9. (Pubitemid 40807295)
20. Pasquier B, Launay P, Kanamaru Y et al. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 2005; 22(1):31-42. (Pubitemid 40143449)
21. Hamerman JA, Tchao NK, Lowell CA et al. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol 2005; 6(6):579-86. (Pubitemid 41710728)
22. Katz HR. Inhibitory receptors and allergy. Curr Opin Immunol 2002; 14(6):698-704. (Pubitemid 35292415)
23. Benhamou M, Bonnerot C, Fridman WH et al. Molecular heterogeneity of murine mast cell Fc gamma receptors. J Immunol 1990; 144(8):3071-7. (Pubitemid 20149482)
24. Daeron M, Malbec O, Latour S et al. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest 1995; 95(2):577-85.
25. Fong DC, Malbec O, Arock M et al. Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated Fc gammaRIIB during negative regulation of IgE-dependent mouse mast cell activation. Immunol Lett 1996; 54(2-3):83-91. (Pubitemid 27086906)
26. Lesourne R, Bruhns P, FridmanWH et al. Insufficient phosphorylation prevents fc gamma RIIB from recruiting the SH2 domain-containing protein-tyrosine phosphatase SHP-1. J Biol Chem 2001; 276(9):6327-36.
27. Malbec O, Attal JP, Fridman WH et al. Negative regulation of mast cell proliferation by FcgammaRIIB. Mol Immunol 2002; 38(16-18):1295-9. (Pubitemid 35253767)
28. Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol 2007; 7(4):255-66. (Pubitemid 46480955)
29. Yokoi H, Myers A, Matsumoto K et al. Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells. Allergy 2006; 61(6):769-76. (Pubitemid 43801413)
30. Floyd H, Ni J, Cornish AL et al. Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily. J Biol Chem 2000; 275(2):861-6. (Pubitemid 30051127)
31. Ghannadan M, Hauswirth AW, Schernthaner GH et al. Detection of novel CD antigens on the surface of human mast cells and basophils. Int Arch Allergy Immunol 2002; 127(4):299-307. (Pubitemid 34522819)
32. Kikly KK, Bochner BS, Freeman SD et al. Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells and basophils. J Allergy Clin Immunol 2000; 105(6 Pt 1):1093-100. (Pubitemid 30418786)
33. Bochner BS. Siglec-8 on human eosinophils and mast cells and Siglec-F on murine eosinophils, are functionally related inhibitory receptors. Clin Exp Allergy 2009; 39(3):317-24.
34. Yokoi H, Choi OH, Hubbard W et al. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. J Allergy Clin Immunol 2008; 121(2):499-505 e1.
35. Tateno H, Crocker PR, Paulson JC. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand. Glycobiology 2005; 15(11):1125-35. (Pubitemid 41662639)
36. Ishida A, Ohta M, Toda M et al. Mucin-induced apoptosis of monocyte-derived dendritic cells during maturation. Proteomics 2008; 8(16):3342-9.
37. Hudson SA, Bovin NV, Schnaar RL et al. Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6'-sulfated sialyl Lewis x. J Pharmacol Exp Ther 2009; 330(2):608-12.
38. Bachelet I, Munitz A, Moretta A et al. The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J Immunol 2005; 175(12):7989-95. (Pubitemid 41798360)
39. Munitz A, Bachelet I, Eliashar R et al. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF and eotaxin on human peripheral blood eosinophils. Blood 2006; 107(5):1996-2003. (Pubitemid 43289383)
40. Alvarez Y, Tang X, Coligan JE et al. The CD300a (IRp60) inhibitory receptor is rapidly up-regulated on human neutrophils in response to inflammatory stimuli and modulates CD32a (FcgammaRIIa) mediated signaling. Mol Immunol 2008; 45(1):253-8. (Pubitemid 47331654)
41. Kumagai H, Oki T, Tamitsu K, Feng SZ et al. Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells. Biochem Biophys Res Commun 2003; 307(3):719-29. (Pubitemid 36944992)
42. Bachelet I, Munitz A, Levi-Schaffer F. Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a. J Allergy Clin Immunol 2006; 117(6):1314-20. (Pubitemid 43795759)
43. Munitz A, Bachelet I, Levi-Schaffer F. Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J Allergy Clin Immunol 2006; 118(5):1082-9. (Pubitemid 44666985)
44. Bustamante CD, Fledel-Alon A, Williamson S et al. Natural selection on protein-coding genes in the human genome. Nature 2005; 437(7062):1153-7. (Pubitemid 41509352)
45. Nielsen R, Bustamante C, Clark AG et al. A scan for positively selected genes in the genomes of humans and chimpanzees. PLoS Biol 2005; 3(6):e170.
46. Clark GJ, Ju X, Tate C et al. The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends Immunol 2009; 30(5):209-17.
47. Li L, Yao Z. Mast cell and immune inhibitory receptors. Cell Mol Immunol 2004; 1(6):408-15.
48. Tedla N, Lee CW, Borges L et al. Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells. J Leukoc Biol 2008; 83(2):334-43. (Pubitemid 351225614)
49. Katz HR. Inhibition of pathologic inflammation by leukocyte Ig-like receptor B4 and related inhibitory receptors. Immunol Rev 2007; 217:222-30. (Pubitemid 46718155)
50. Katz HR, Vivier E, Castells MC et al. Mouse mast cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation when coligated with the high-affinity Fc receptor for IgE. Proc Natl Acad Sci USA 1996; 93(20):10809-14. (Pubitemid 26333071)
51. Lu-Kuo JM, Joyal DM, Austen KF et al. gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of src homology 2 domain-containing phosphatase-1 and suppression of early and late calcium mobilization. J Biol Chem 1999; 274(9):5791-6. (Pubitemid 29109235)
52. Daheshia M, Friend DS, Grusby MJ et al. Increased severity of local and systemic anaphylactic reactions ingp49B1-deficientmice. JExp Med2001; 194(2):227-34.
53. Zhou JS, Friend DS, Feldweg AM et al. Prevention oflipopolysaccharide- induced microangiopathy by gp49B1: evidence for an important role for gp49B1 expression on neutrophils. J Exp Med 2003; 198(8):1243-51. (Pubitemid 37323389)
54. Castells MC, Klickstein LB, Hassani K et al. gp49B1-alpha(v)beta3 interaction inhibits antigen-induced mast cell activation. Nat Immunol 2001; 2(5):436-42. (Pubitemid 33706142)
55. Chen CC, Hurez V, Brockenbrough JS et al. Paternal monoallelic expression ofthe paired immunoglobulin-like receptors PIR-A and PIR-B. Proc Natl Acad Sci USA 1999; 96(12):6868-72. (Pubitemid 29274976)
56. Uehara T, Blery M, Kang DW et al. Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B. J Clin Invest 2001; 108(7):1041-50. (Pubitemid 32946078)
57. Blery M, Kubagawa H, Chen CC et al. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc Natl Acad Sci USA 1998; 95(5):2446-51. (Pubitemid 28145961)
58. Nakamura A, Kobayashi E, Takai T. Exacerbated graft-versus-host disease in Pirb-/- mice. Nat Immunol 2004; 5(6):623-9. (Pubitemid 38811887)
59. Verbrugge A, Ruiter Td T, Clevers H et al. Differential contribution of the immunoreceptor tyrosine-based inhibitory motifs ofhuman leukocyte-associated Ig-like receptor-1 to inhibitory function and phosphatase recruitment. Int Immunol 2003; 15(11):1349-58. (Pubitemid 37369328)
60. Meyaard L. The inhibitory collagen receptor LAIR-1 (CD305). J Leukoc Biol 2008; 83(4):799-803. (Pubitemid 351959858)
61. Meyaard L, Adema GJ, Chang C et al. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 1997; 7(2):283-90. (Pubitemid 27392019)
62. Fournier N, Chalus L, Durand I et al. FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells. J Immunol 2000; 165(3):1197-209. (Pubitemid 30604545)
63. Verbrugge A, Rijkers ES, de Ruiter T et al. Leukocyte-associated Ig-like receptor-1 has SH2 domain-containing phosphatase-independent function and recruits C-terminal Src kinase. Eur J Immunol 2006; 36(1):190-8. (Pubitemid 43116405)
64. Zhang S, Phillips JH. Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activation. J Leukoc Biol 2006; 79(2):363-8. (Pubitemid 44831168)
65. Shiratori I, Yamaguchi M, Suzukawa M et al. Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200. J Immunol 2005; 175(7):4441-9. (Pubitemid 41361980)
66. Zhang S, Cherwinski H, Sedgwick JD et al. Molecular mechanisms of CD200 inhibition of mast cell activation. J Immunol 2004; 173(11):6786-93. (Pubitemid 39545181)
67. Cherwinski HM, Murphy CA, Joyce BL et al. The CD200 receptor is a novel and potent regulator ofmurine and human mast cell function. J Immunol 2005; 174(3):1348-56.
68. Abramson J, Pecht I. Regulation of the mast cell response to the type 1 Fc epsilon receptor. Immunol Rev 2007; 217:231-54. (Pubitemid 46718151)
69. Pinter E, Barreuther M, Lu T et al. Platelet-endothelial cell adhesion molecule-1 (PECAM- 1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus. Am J Pathol 1997; 150(5):1523-30. (Pubitemid 27193801)
70. Jackson DE. The unfolding tale of PECAM-1. FEBS Lett 2003; 540(1-3):7-14. (Pubitemid 36398025)
71. Sagawa K, Swaim W, Zhang J et al. Aggregation of the high affinity IgE receptor results in the tyrosine phosphorylation ofthe surface adhesion protein PECAM-1 (CD31). J Biol Chem 1997; 272(20):13412-8. (Pubitemid 27216775)
72. Hua CT, Gamble JR, Vadas MA et al. Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates. J Biol Chem 1998; 273(43):28332-40. (Pubitemid 28496134)
73. Piali L, Hammel P, Uherek C et al. CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol 1995; 130(2):451-60.
74. Deaglio S, Morra M, Mallone R et al. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol 1998; 160(1):395-402. (Pubitemid 28116754)
75. Abramson J, Xu R, Pecht I. An unusual inhibitory receptor-the mast cell function-associated antigen (MAFA). Mol Immunol 2002; 38(16-18):1307-13. (Pubitemid 35253769)
76. Ortega Soto E, Pecht I. A monoclonal antibody that inhibits secretion from rat basophilic leukemia cells and binds to a novel membrane component. J Immunol 1988; 141(12):4324-32. (Pubitemid 19018224)
77. Abramson J, Licht A, Pecht I. Selective inhibition of the Fc epsilon RI-induced de novo synthesis of mediators by an inhibitory receptor. EMBO J 2006; 25(2):323-34. (Pubitemid 43152853)
78. Xu R, Abramson J, Fridkin M et al. SH2 domain-containing inositol polyphosphate 5'-phosphatase is the main mediator of the inhibitory action of the mast cell function-associated antigen. J Immunol 2001; 167(11):6394-402. (Pubitemid 33081572)
79. Grundemann C, Bauer M, Schweier O et al. Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1. J Immunol 2006; 176(3):1311-5.
80. Ito M, Maruyama T, Saito N et al. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J Exp Med 2006; 203(2):289-95. (Pubitemid 43290837)
81. Tessmer MS, Fugere C, Stevenaert F et al. KLRG1 binds cadherins and preferentially associates with SHIP-1. Int Immunol 2007; 19(4):391-400. (Pubitemid 46523387)
82. Schwartzkopff S, Grundemann C, Schweier O et al. Tumor-associated E-cadherin mutations affect binding to the killer cell lectin-like receptor G1 in humans. J Immunol 2007; 179(2):1022-9.
83. Wu HJ, Bondada S. CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function. J Clin Immunol 2009; 29(1):12-21.
84. Von Hoegen I, Nakayama E, Parnes JR. Identification of a human protein homologous to the mouse Lyb-2 B-cell differentiation antigen and sequence ofthe corresponding cDNA. J Immunol 1990; 144(12):4870-7. (Pubitemid 20224129)
85. Grupp SA, Harmony JA, Baluyut AR et al. Early events in B-cell activation: anti-Lyb2, but not BSF-1, induces a phosphatidylinositol response in murine B cells. Cell Immunol 1987; 110(1):131-9. (Pubitemid 18002670)
86. Polla BS et al. Differential induction of class II gene expression in murine preB-cell lines by B-cell stimulatory factor-1 and by antibodies to B-cell surface antigens. J Mol Cell Immunol 1988; 3(6):363-73.
87. Subbarao B, Morris J, Baluyut AR. Properties of anti-Lyb-2-mediated B-cell activation and the relationship between Lyb-2 molecules and receptors for B-cell stimulatory factor-1 on murine B-lymphocytes. Cell Immunol 1988; 112(2):329-42.
88. Kumanogoh A, Watanabe C, Lee I et al. Identification ofCD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B-cell signaling. Immunity 2000; 13(5):621-31.
89. Kataoka TR, Kumanogoh A, Bandara G et al. CD72 negatively regulates KIT-mediated responses in human mast cells. J Immunol 184(5):2468-75.
90. Tam SW, Demissie S, Thomas D et al. Abispecific antibody against human IgE andhuman FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils. Allergy 2004; 59(7):772-80. (Pubitemid 38850354)
91. Zhu D, Kepley CL, Zhang M et al. A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation. Nat Med 2002; 8(5):518-21. (Pubitemid 34546756)
92. Zhang K, Kepley CL, Terada T et al. Inhibition of allergen-specific IgE reactivity by a human Ig Fcgamma-Fcepsilon bifunctional fusion protein. J Allergy Clin Immunol 2004; 114(2):321-7. (Pubitemid 39119031)